Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome

Cardio-renal-metabolic (CRM) syndrome, which involves type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and heart failure (HF), is a serious healthcare issue globally, with high morbidity and mortality. The disorders that comprise CRM syndrome are independent can mutually affect and acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyama, Hiroki, Nishimura, Akihiro, Morita, Naru, Yajima, Toshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922689/
https://www.ncbi.nlm.nih.gov/pubmed/36793276
http://dx.doi.org/10.3389/fendo.2023.1111984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922689/
https://www.ncbi.nlm.nih.gov/pubmed/36793276
http://dx.doi.org/10.3389/fendo.2023.1111984

Ejemplares similares